Skye Bioscience (SKYE) Asset Utilization Ratio (2013)
Skye Bioscience (SKYE) posted quarterly Asset Utilization Ratio of 2.48 for Q4 2013.
Skye Bioscience (SKYE) Asset Utilization Ratio (2013) Analysis & Trends
Skye Bioscience (SKYE) has reported Asset Utilization Ratio for 1 consecutive years, with 2.48 the latest figure, recorded in Q4 2013.
- In Q4 2013, Asset Utilization Ratio changed N/A year-over-year to 2.48; the TTM figure through Oct 2013 stood at 2.48 (changed N/A YoY), while the FY2013 annual figure was 3.61, changed N/A from the prior year.
- Asset Utilization Ratio steadied at 2.48 in Q4 2013 per SKYE's latest filing.
- Across five years, Asset Utilization Ratio topped out at 2.48 in Q4 2013 and bottomed at 2.48 in Q4 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 0.20 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.69 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 0.90 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.13 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 0.54 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.13 |
| 10 | Skye Bioscience | 10.86 Mn | 10.86 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2013 | 2.48 |